(REDWOOD CITY, Calif.)PDL BioPharma Inc. said Thursday its board of directors named Faheem Hasnain president and chief executive of its planned spinoff company, Facet Biotech Corp.READ MORE

(NEW YORK)Shares of PDL BioPharma Inc. fell Thursday following negative comments by JP Morgan which called the biotechnology company's royalty stream and development pipeline overvalued by W...READ MORE

Among the stock activity stories for Thursday, Sept. 11, from AP Financial News: NEW YORK (AP)--Shares of Titan International Inc. rose Thursday after the maker of off-road vehicle...READ MORE

(NEW YORK)PDL BioPharma Inc.'s stock gained ground Wednesday after pharma giant Bristol-Myers Squibb Co. signed a deal to license the biotechnology company's developing blood cancer drug.READ MORE

Among the stock activity stories for Wednesday, Aug. 20, from AP Financial News: NEW YORK (AP)--Shares of Tween Brands Inc. rose on Wednesday, after an analyst said the apparel ret...READ MORE

(PRINCETON, N.J.)Drugmaker Bristol-Myers Squibb Co. said Tuesday it will pay $30 million to acquire rights to an experimental treatment for blood cancer from PDL BioPharma Inc.READ MORE

(REDWOOD CITY, Calif.)PDL BioPharma Inc. said late Monday its chief scientific officer, Richard Murray, will resign to pursue other interests. Murray's resignation is effective Sept. 5.READ MORE